Pharmaceutical giant Roche inaugurated Switzerland’s tallest building on Friday. The 205-metre-tall structure in Basel, known as Building 2, will house 3,500 workers.
The new high rise surpasses the firm’s nearby tower – Building 1 – which stands at 178 metres.
The new 50-floor high-rise office, with a total floor space of 83,000 metres, was designed by the renowned Swiss architectural firm Herzog & de Meuron; it cost CHF550 million ($561 million) to build.
The white, sleek staircase shaped towers can be seen from nearly everywhere in Basel in northwest Switzerland.
“Building 2 is another highly visible sign of Roche’s commitment to Basel – the city where Roche was founded over 125 years ago,” said Roche CEO Severin Schwan in a statementExternal link on Friday.
Tight planning regulation restrictions in many Swiss urban areas mean that there are few skyscrapers in Switzerland.
The construction of the twin towers in Basel allows Roche to bring together staff who were previously working in different locations across the city. Two thousand employees work in Building 1.
The pharma giant is continuing its investment in Basel with plans for a new CHF1.2 billion research & development centre, which is due to open in autumn 2024.
Roche is one of the biggest private employers in Switzerland with 15,000 staff based on four sites (two in Basel, and others in Zurich and Rotkreuz); it employs 100,000 people worldwide.
Popular Stories
More
Culture
Documentary portrays Swiss teenagers forced to return to parents’ homeland
Swiss university graduates are popular hires worldwide
This content was published on
Graduates of Swiss universities are popular with international employers, according to the Global Employability University Rankings.
French cross-border workers in Switzerland fear ‘discriminatory’ unemployment reform
This content was published on
In the French region around Geneva, cross-border workers are protesting proposals to cut unemployment benefits for those working in Switzerland.
Swan infected with bird flu in central Switzerland
This content was published on
Switzerland has reported its first bird flu case of the season. A swan found dead in central Switzerland tested positive for the H5N1 virus.
Swiss researchers identify gene variants linked to cancer progression
This content was published on
ETH Zurich researchers explored genetic mutations’ effects on cell function and their role in cancer development and treatment using CRISPR/Cas techniques.
Explosion at Swiss company Givaudan’s US plant leaves two dead
This content was published on
Swiss flavour and fragrance maker Givaudan reported that an explosion at its Kentucky plant resulted in two deaths and several injuries.
Swisscom’s Vodafone Italia takeover cleared by Italian telecoms authority
This content was published on
Swisscom is one step closer to its planned acquisition of Vodafone Italia, as the Italian communications regulator has approved the €8 billion deal.
Swiss parliamentary committee proposes foreign aid cuts and military funding boost
This content was published on
A committee of the Swiss House of Representatives has proposed increasing funds for the military and agriculture while reducing foreign aid and asylum.
Swiss Rolex Submariner watches reach nearly $50 billion in total market value
This content was published on
The total market value of all Rolex Submariner watches ever made is nearly $50 billion, based on newly released production data.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What’s behind the Novartis job cuts?
This content was published on
The recent decision by the Swiss drugmaker to shed 7% of its workforce is more than just a cost-cutting measure - it’s a turning point for Novartis.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.